Neurology: Volume 84, Number 23, June 9, 2015
About this course
- Released: 06/09/2015
- Expires: 06/09/2018
OVERVIEW:
TIME FROM CONVULSIVE STATUS EPILEPTICUS ONSET TO ANTICONVULSANT ADMINISTRATION IN CHILDREN
LEARNING OBJECTIVES:
Upon completion of the article by Sánchez Fernández et al, the participant should be able to:
- Recognize that status epilepticus (SE) is one of the most common pediatric neurologic emergencies, with significant morbidity and mortality
- Discuss the importance of SE duration as a potentially modifiable factor impacting outcome
- Discuss the results of this study assessing the timing and escalation of antiepileptic drug (AED) administration in pediatric convulsive SE in the prehospital and in-hospital settings
CORE COMPETENCIES:
The article by Sánchez Fernández et al covers the following core competency:
- Medical Knowledge
- Systems Based Practice
TETRAHYDROCANNABINOL FOR NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA: A RANDOMIZED CONTROLLED TRIAL
LEARNING OBJECTIVES:
Upon completion of the article by van den Elsen et al, the participant should be able to:
- Recognize that most patients with dementia will experience neuropsychiatric symptoms (NPS) over the course of their disease
- Recognize that while nonpharmacologic interventions are preferred for NPS in dementia, data on their efficacy is limited, and that currently available medications have important drawbacks concerning their benefit-to-risk ratio
- Discuss the action of tetrahydrocannabinol (THC) on endocannabinoid receptors
- Discuss the findings from this study assessing the efficacy and safety of low-dose oral THC in the treatment of dementia-related NPS
CORE COMPETENCIES:
The article by van den Elsen et al covers the following core competency:
- Medical Knowledge
AUTHOR DISCLOSURES:
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
